100 participants
Gefitinib With Chemotherapy or Anti-angiogenesis in NSCLC Patients With Bim Deletion or Low EGFR Mutation Abundance
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2020-08-03
- Start Date:
- 2017-10-12
- Completion:
- 2020-10-20
Conditions
- Non-small-cell Lung Cancer
Interventions
- DRUG
No Results Yet